pulm 3/27 pt 2

Swan-Ganz Catheter and Pulmonary Hypertension

  • Swan-Ganz Catheter

    • Definition: A special catheter threaded through neck veins into the pulmonary artery to measure pressures.

    • Provides measurement of pulmonary wedge pressure.

    • Normally measures 25 millimeters at rest.

Types of Pulmonary Hypertension

  • Five Classes of Pulmonary Hypertension

    • Impacts small pulmonary muscular arteries, leading to enlargement of arteries in the lungs.

    • Can be secondary to conditions such as:

    • Left-sided heart failure: Prolonged failure of the left side affects the right side, leading to pulmonary hypertension.

    • Lung parenchymal diseases: E.g., COPD (Chronic Obstructive Pulmonary Disease) can induce pulmonary hypertension.

    • Thrombotic or embolic phenomena: Blood clots in the lung.

    • Multi-factorial causes: Several contributing factors can lead to pulmonary hypertension.

Clinical Manifestations of Right-Sided Heart Failure

  • Patients with right-sided heart failure may present with:

    • Fatigue

    • Increased jugular venous pressure: Seen through the enlargement of jugular veins.

    • Backup of blood: Can back up to the liver, causing:

    • Ascites: Fluid accumulation in the abdominal cavity.

    • Hepatomegaly: Enlargement of the liver.

    • Splenomegaly: Enlargement of the spleen.

    • Peripheral edema: Fluid buildup in the systemic venous system.

    • Gastrointestinal distress: Reduced appetite, nausea.

Other Causes of Pulmonary Hypertension

  • Autoimmune causes: Conditions that incite inflammation of small pulmonary arteries, including:

    • Systemic sclerosis: Autoimmune disease impacting the skin and internal organs.

    • HIV and infections: Certain infections can worsen pulmonary health.

  • Obstructive sleep apnea: Often linked to obesity; increases abdominal pressure, reducing venous return and inducing hypoxemia.

  • Idiopathic pulmonary hypertension: Exclusion of other potential causes, may be due to genetic factors including mutations in the BMPR2 gene.

Genetic Aspects of Pulmonary Hypertension

  • BMPR2 Gene

    • Bone morphogenic protein receptor (BMPR2) related to transforming growth factor.

    • Pathophysiology: Mutations lead to endothelial dysfunction.

    • Causes proliferation of endothelial and small muscle cells, obstructing pulmonary vasculature.

    • Associated with concentric fibrosis of pulmonary arteries.

    • Found on chromosome 2.

Implications of Atherosclerosis and Other Conditions

  • Medial hypertrophy: A common feature across forms of pulmonary hypertension affecting muscular arteries in the pulmonary bed.

  • Atherosclerosis: Can cause occlusion of pulmonary arteries, worsening hypertensive conditions.

    • Recanalization: If atherosclerotic changes occur alongside recanalization, it can lead to embolic events that exacerbate the patient's condition.

Clinical Features of Idiopathic Pulmonary Hypertension

  • Demographics: Most commonly affects women aged 20-40 and children.

  • Symptoms: Dyspnea, fatigue, rarely chest pain, respiratory distress, cyanosis, right ventricular hypertrophy.

  • Mortality rate: Approximately 80% within 2-5 years if untreated.

Treatment Options for Pulmonary Hypertension

  • Short-term treatments:

    • Oxygen therapy: Improving oxygenation.

    • Calcium channel blockers: To reduce vascular resistance and improve flow.

    • Anticoagulants: Prevent blood clot formation.

    • Digoxin: Increases cardiac contractility.

    • Diuretics: Reduce fluid overload.

  • Advanced treatments:

    • Prostacyclin therapy: Mimics prostaglandin effects to induce vasodilation.

    • Lung transplant: Considered definitive therapy in advanced cases.

Diffuse Pulmonary Hemorrhagic Syndromes

  • Goodpasture's Syndrome

    • Affects lungs and kidneys; leads to hemoptysis and renal failure.

    • Mechanism: Autoantibodies target the alpha-3 chain of collagen IV, damaging the basement membranes of both organs.

    • Symptoms: Coughing up blood, rapid renal failure, lung consolidations seen on X-ray or CT.

  • Idiopathic pulmonary hemosiderosis: Rare disease, primarily affects children but can occur in adults; presents similarly to Goodpasture’s with hemoptysis and potential renal involvement.

Wegener's Granulomatosis

  • Characteristics: An autoimmune vasculitis affecting lungs and upper respiratory tract.

    • Symptoms: Nosebleeds, saddle nose deformity, hemoptysis, kidney failure.

    • Differential diagnosis: Distinguishing symptoms from Goodpasture's involves noting upper respiratory tract symptoms like sinusitis.

  • Management: Involves immunosuppressive therapy due to autoimmune nature of the disease.

Conclusion

  • Urgency of Treatment: Early and aggressive management of pulmonary hypertension is crucial to improve outcomes and prevent morbidity and mortality.